Vancouver, BC (May 20, 2014) – Terramera, a pioneer in developing effective and safe bio-pesticides for pest management, announced the addition of Doug Chou as a Senior Scientist to their R&D team. Dr. Chou brings over 10 years of hands on experience in the pharmaceutical industry. His broad background includes process development, technology transfer, project management and manufacturing of drug substances.
According to Dr. Annett Rozek, Terramera’s Chief Scientific Officer, “Dr. Chou will play a crucial role in enhancing our process development. He brings extensive experience in the development and management of processes, formulations and in QA/QC. At Cardiome Pharma Corp. he was a key member of a team that completed the syntheses and regulatory documentations of reference standards, process impurities, and degradants for Brinavess™ NDA, approved in Europe and Latin America (intravenous formulation) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.”
“I’m thrilled to join Terramera and contribute to this incredibly versatile, multidisciplinary team. It is incredibly satisfying to be part of a company that is dedicated and poised to make a major environmental impact on our lives through the development of effective products for sustainable pest management.”
About Terramera: Terramera, Inc., is a Vancouver (Canada)-based biotechnology company developing sustainable pest control solutions as alternatives to traditional chemical pesticides. Terramera’s goal is to develop safe and effective bio-products, including bio-pesticides that are safer and more effective than conventional chemical pesticides. Terramera is committed to providing safe and innovative products trusted to protect every person and family from the fear and threat of pests.
Terry Taciuk, Marketing